50 related articles for article (PubMed ID: 38600588)
1. Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like polarization.
Wu D; Gong T; Sun Z; Yao X; Wang D; Chen Q; Guo Q; Li X; Guo Y; Lu Y
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131826. PubMed ID: 38679256
[TBL] [Abstract][Full Text] [Related]
2. VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.
Li H; Ruan Y; Liu C; Fan X; Yao Y; Dai Y; Song Y; Jiang D; Sun N; Jiao G; Chen Z; Fan S; Meng F; Yang H; Zhang Y; Li Z
Cell Commun Signal; 2024 Apr; 22(1):224. PubMed ID: 38600588
[TBL] [Abstract][Full Text] [Related]
3. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
4. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.
Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A
Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance.
Jiang S; Deng T; Cheng H; Liu W; Shi D; Yuan J; He Z; Wang W; Chen B; Ma L; Zhang X; Gong P
J Exp Clin Cancer Res; 2023 Aug; 42(1):199. PubMed ID: 37553567
[TBL] [Abstract][Full Text] [Related]
6. The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis.
Hu WM; Liu SQ; Zhu KF; Li W; Yang ZJ; Yang Q; Zhu ZC; Chang J
Int Immunopharmacol; 2023 Aug; 121():110505. PubMed ID: 37348233
[TBL] [Abstract][Full Text] [Related]
7. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression.
Wei D; Wang L; Liu Y; Hafley MA; Tan L; Lorenzi PL; Yang P; Zuo X; Bresalier RS
Dig Dis Sci; 2023 Jul; 68(7):3043-3058. PubMed ID: 37071246
[TBL] [Abstract][Full Text] [Related]
8. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts.
Visvanathan K; Mondul AM; Zeleniuch-Jacquotte A; Wang M; Gail MH; Yaun SS; Weinstein SJ; McCullough ML; Eliassen AH; Cook NR; Agnoli C; Almquist M; Black A; Buring JE; Chen C; Chen Y; Clendenen T; Dossus L; Fedirko V; Gierach GL; Giovannucci EL; Goodman GE; Goodman MT; Guénel P; Hallmans G; Hankinson SE; Horst RL; Hou T; Huang WY; Jones ME; Joshu CE; Kaaks R; Krogh V; Kühn T; Kvaskoff M; Lee IM; Mahamat-Saleh Y; Malm J; Manjer J; Maskarinec G; Millen AE; Mukhtar TK; Neuhouser ML; Robsahm TE; Schoemaker MJ; Sieri S; Sund M; Swerdlow AJ; Thomson CA; Ursin G; Wactawski-Wende J; Wang Y; Wilkens LR; Wu Y; Zoltick E; Willett WC; Smith-Warner SA; Ziegler RG
Eur J Epidemiol; 2023 Jan; 38(1):11-29. PubMed ID: 36593337
[TBL] [Abstract][Full Text] [Related]
9. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D as a chemopreventive agent in colorectal neoplasms. A systematic review and meta-analysis of randomized controlled trials.
Emmanouilidou G; Kalopitas G; Bakaloudi DR; Karanika E; Theocharidou E; Germanidis G; Chourdakis M
Pharmacol Ther; 2022 Sep; 237():108252. PubMed ID: 35926664
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-β1/thrombospondin-1 axis.
Kitami K; Yoshihara M; Tamauchi S; Sugiyama M; Koya Y; Yamakita Y; Fujimoto H; Iyoshi S; Uno K; Mogi K; Ikeda Y; Yokoi A; Yoshikawa N; Nishino K; Niimi K; Nawa A; Enomoto A; Kajiyama H
Matrix Biol; 2022 May; 109():70-90. PubMed ID: 35339636
[TBL] [Abstract][Full Text] [Related]
12.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
